Biotinylated Cynomolgus / Rhesus macaque TIGIT Protein, His,Avitag™ (MALS verified)

Customer Reviews
Cat. No. / Size
Price
Qty
TIT-C82E3-25ug
$360.00
TIT-C82E3-200ug
$1420.00
ETA of in-stock products:2 business days

Product Details

  • Synonyms

    TIGIT, VSIG9, VSTM3

  • Source

    Biotinylated Cynomolgus / Rhesus macaque TIGIT Protein, His,Avitag (TIT-C82E3) is expressed from human 293 cells (HEK293). It contains AA Met 89 - Ile 208 (Accession # G7NXM4-1). In the region Met 89 - Ile 208, the amino acid sequences of Cynomolgus and Rhesus macaque TIGIT are identical.

    Predicted N-terminus: Met 89

  • Molecular Characterization

    This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™).

    The protein has a calculated MW of 31.0 kDa. The protein migrates as 33-43 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Purity

    >90% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Shipping and Storage

    This product is shipped at ambient temperature.

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    TIGIT SDS-PAGE

    Biotinylated Cynomolgus / Rhesus macaque TIGIT Protein, His,Avitag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    TIGIT SEC-MALS

    The purity of Biotinylated Cynomolgus / Rhesus macaque TIGIT Protein, His,Avitag (Cat. No. TIT-C82E3) is more than 95% and the molecular weight of this protein is around 30-45 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     TIGIT ELISA

    Immobilized Human CD155, Fc Tag (Cat. No. CD5-H5251) at 5 μg/mL (100 μL/well) can bind Biotinylated Cynomolgus / Rhesus macaque TIGIT Protein, His,Avitag (Cat. No. TIT-C82E3) with a linear range of 4-125 ng/mL (QC tested).

    Protocol
  •  TIGIT ELISA

    Immobilized Anti-TIGIT Antibody, Human IgG1 at 1 μg/mL (100 μL/well) can bind Biotinylated Cynomolgus / Rhesus macaque TIGIT Protein, His,Avitag (Cat. No. TIT-C82E3) with a linear range of 0.06-2 ng/mL (Routinely tested).

    Protocol

Customer Reviews
Writing Reviews

Background

T-cell immunoreceptor with Ig and ITIM domains (TIGIT) is also known as V-set and immunoglobulin domain-containing protein 9 (VSIG9), V-set and transmembrane domain-containing protein 3 (VSTM3),which belongs to single-pass type I membrane protein containing an immunoglobulin variable domain, a transmembrane domain and an immunoreceptor tyrosine-based inhibitory motif (ITIM). TIGIT is expressed at low levels on peripheral memory and regulatory CD4+ T-cells and NK cells and is up-regulated following activation of these cells (at protein level). TIGIT binds with high affinity to the poliovirus receptor (PVR) which causes increased secretion of IL10 and decreased secretion of IL12B and suppresses T-cell activation by promoting the generation of mature immunoregulatory dendritic cells.

Recent Advances

 
Drug Development Progress
  • English Name:

    T cell immunoglobulin and ITIM domains

  • Category:

  • Approved Drugs:

    0 Details

  • Drugs in Clinical Trials:

    41 Details

  • Highest Development Stage:

    Phase 3 Clinical

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background
Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8